Form 8-K - Current report:
SEC Accession No. 0001021771-25-000074
Filing Date
2025-04-21
Accepted
2025-04-21 16:08:50
Documents
14
Period of Report
2025-04-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CHANGE IN ACCOUNTANTS brt42125.htm   iXBRL 8-K 29914
2 MARCUM RESIGNATION LETTER ex16.htm EX-16 2594
  Complete submission text file 0001021771-25-000074.txt   168642

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA brtx-20250416.xsd EX-101.SCH 4001
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20250416_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20250416_pre.xml EX-101.PRE 16057
16 EXTRACTED XBRL INSTANCE DOCUMENT brt42125_htm.xml XML 4031
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 25853211
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)